Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Nashira Popovic
Observed name:
N Popovic
Institutions:
Public Health Agency of Canada,
McGill University Health Centre,
Research Institute of the McGill University Health Centre
Observed institutions:
Public Health Agency of Canada,
McGill University Health Centre,
Research Institute of the McGill University Health Centre
ORCID:
0009-0007-3841-5841
Observed ORCID:
0009-0007-3841-5841
OpenAlex ID:
A5028223337
HIV in Canada—Surveillance Report, 2018
2019
·
N Haddad
, A Robert
, et al.
·
Canada Communicable Disease Report
·
128
PDF
Rising syphilis rates in Canada, 2011–2020
2022
·
Josephine Aho
, Cassandra Lybeck
, et al.
·
Canada Communicable Disease Report
·
99
PDF
The hepatitis C epidemic in Canada: An overview of recent trends in surveillance, injection drug use, harm reduction and treatment
2021
·
Lillian Lourenço
, Marian Kelly
, et al.
·
Canada Communicable Disease Report
·
35
PDF
National Hepatitis C estimates: Incidence, prevalence, undiagnosed proportion and treatment, Canada, 2019
2022
·
Nashira Popovic
, Anson Williams
, et al.
·
Canada Communicable Disease Report
·
32
PDF
Trends in HIV pre-exposure prophylaxis use in eight Canadian provinces, 2014–2018
2021
·
Nashira Popovic
, Qiuying Yang
, et al.
·
Canada Communicable Disease Report
·
20
PDF
Estimation of the population size of gay, bisexual and other men who have sex with men in Canada, 2020
2023
·
Justin Sorge
, Sean Colyer
, et al.
·
Canada Communicable Disease Report
·
19
PDF
Newly diagnosed cases of HIV in those aged 50 years and older and those less than 50: 2008–2017
2019
·
N Haddad
, A Robert
, et al.
·
Canada Communicable Disease Report
·
18
PDF
National hepatitis B and C estimates for 2021: Measuring Canada’s progress towards eliminating viral hepatitis as a public health concern
2025
·
Simone Périnet
, Anson Williams
, et al.
·
Canada Communicable Disease Report
·
12
PDF
The prevalence of HIV pre-exposure prophylaxis (HIV-PrEP) use and HIV-PrEP-to-need ratio in nine Canadian provinces, 2018–2021
2025
·
Nashira Popovic
, Qiuying Yang
, et al.
·
Canada Communicable Disease Report
·
12
PDF
Estimated prevalence of hepatitis B and C among immigrants in Canada
2025
·
Laurence Campeau
, Janelle Elliott
, et al.
·
Canada Communicable Disease Report
·
8
PDF
Improving national surveillance of new HIV diagnoses
2019
·
N Popovic
, Q Yang
, et al.
·
Canada Communicable Disease Report
·
7
PDF
Estimating the population size of people who inject drugs in Canada, 2021
2025
·
Anson Williams
, Justin Sorge
, et al.
·
Canada Communicable Disease Report
·
5
PDF
A two-day workshop reviewing Canadian provincial and national HIV care cascade indicators, reporting, challenges, and recommendations
2022
·
Ioana A Nicolau
, Mostafa Shokoohi
, et al.
·
Journal of the Association of Medical Microbiology and Infectious Disease Canada
·
5
Cas de VIH nouvellement diagnostiqués chez les personnes de 50 ans et plus, comparativement aux personnes de moins de 50 ans : 2008 à 2017
2019
·
N Haddad
, A Robert
, et al.
·
Relevé des maladies transmissibles au Canada
·
4
PDF
Navigating harm reduction and security mandates: Prison leadership perspectives on implementing prison needle exchange programs in Canada
2026
·
Lise Lafferty
, Nashira Popovic
, et al.
·
International Journal of Drug Policy
·
3
Estimations nationales de l'hépatite B et de l'hépatite C pour 2021 : mesurer les progrès réalisés par le Canada vers l'élimination de l'hépatite virale en tant que problème de santé publique
2025
·
Simone Périnet
, Anson Williams
, et al.
·
Relevé des maladies transmissibles au Canada
·
3
PDF
Hausse des taux de syphilis au Canada, 2011 à 2020
2022
·
Josephine Aho
, Cassandra Lybeck
, et al.
·
Relevé des maladies transmissibles au Canada
·
3
PDF
Gatekeeping harm reduction in Canadian Federal Prisons: Perspectives on the threat risk assessment for the prison needle exchange program by prison administrative leadership
2026
·
Nadine Kronfli
, Nashira Popovic
, et al.
·
Addiction
·
2
Estimations nationales de l'hépatite C : incidence, prévalence, proportion non diagnostiquée et traitement, Canada, 2019
2022
·
Nashira Popovic
, Anson Williams
, et al.
·
Relevé des maladies transmissibles au Canada
·
2
PDF
Migration pathways and HIV care Cascade among newly enrolled adult patients in a tertiary clinic in Montréal, Canada
2026
·
Kathy Nodzynski
, David Lessard
, et al.
·
HIV Medicine
·
1
Estimation de la prévalence de l'hépatite B et C chez les immigrants au Canada
2025
·
Laurence Campeau
, Janelle Elliott
, et al.
·
Relevé des maladies transmissibles au Canada
·
1
PDF
Prévalence de l'hépatite B et de l'hépatite C, connaissance de son infection, et immunité à l'hépatite B induite par un vaccin : résultats de l'Enquête canadienne sur les mesures de la santé, 2016–2019
2025
·
Simone Périnet
, Anson Williams
, et al.
·
Relevé des maladies transmissibles au Canada
·
1
PDF
Estimation de la prévalence de l'hépatite B et C chez les immigrants au Canada
2025
·
Laurence Campeau
, Janelle Elliott
, et al.
·
Relevé des maladies transmissibles au Canada
·
1
PDF
Estimating Chronic Hepatitis B Prevalence and Undiagnosed Proportion in Canada, 2007-2021: Mathematical Framework Development
2025
·
Julien Smith-Roberge
, Farinaz Forouzannia
, et al.
·
JMIR Public Health and Surveillance
·
1
PDF
Prévalence de l'utilisation de la prophylaxie préexposition au VIH (PPrE) et ratio PPrE-aux-besoins dans neuf provinces canadiennes, 2018–2021
2025
·
Nashira Popovic
, Qiuying Yang
, et al.
·
Relevé des maladies transmissibles au Canada
·
1
PDF
Show more works
View as search
Works count:
30
Citation count:
426
H-index:
9
I10-index:
9
Year
Topic
Type